About SIDAM
SIDAM is a company based in Mirandola (Italy) founded in 1991 by Graziano Azzolini was acquired by Mandarin Capital Partners in September 2020.. SIDAM offers products and services including Pressure Measurement Devices, Infusion Systems, and Radiology Devices. SIDAM operates in a competitive market with competitors including Eurofins Scientific, WuXi AppTec, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others.
- Headquarter Mirandola, Italy
- Founders Graziano Azzolini
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sidam S.R.L.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$386.15 K (USD), Grant
Dec 01, 2020
-
Investors
European Union
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Mandarin Capital Partners
(Sep 03, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SIDAM
SIDAM offers a comprehensive portfolio of products and services, including Pressure Measurement Devices, Infusion Systems, and Radiology Devices. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Tools for monitoring esophageal and intradominal pressure in intensive care.
IV-sets for specific therapies like pain management.
Devices for contrast transfer in CT, MR, and angiography.
Funding Insights of SIDAM
- Total Funding Total Funding
- Total Rounds 1
- Last Round Grant — $386,151
-
First Round
First Round
(01 Dec 2020)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2020 | Amount | Grant - SIDAM | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SIDAM
SIDAM has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Mandarin Capital Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SIDAM
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - SIDAM
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sidam Comparisons
Competitors of SIDAM
SIDAM operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Eurofins Scientific, WuXi AppTec, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Laboratory testing and contract research services are provided globally.
|
|
| domain | founded_year | HQ Location |
Provider of CRO and CDMO services
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
|
|
| domain | founded_year | HQ Location |
Branded pharmaceutical products are developed, marketed, and distributed globally.
|
|
| domain | founded_year | HQ Location |
Branded and generic prescription drugs are developed, manufactured, and marketed.
|
|
| domain | founded_year | HQ Location |
CRO focused on clinical development for phases II & III clinical trials and regulatory affair services
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about SIDAM
When was SIDAM founded?
SIDAM was founded in 1991 and raised its 1st funding round 29 years after it was founded.
Where is SIDAM located?
SIDAM is headquartered in Mirandola, Italy. It is registered at Mirandola, Emilia-romagna, Italy.
What does SIDAM do?
SIDAM was established in 1991 in Mirandola, Italy, within the medical devices sector. Infusion systems are produced for hospital applications. Medical devices such as the Nutrient and electromedical equipment like the Optivent are manufactured for resuscitation departments. Disposable medical devices, electromedical equipment, and thermostatic cells are created for imaging diagnostics, supporting clinical operations across these areas.
Who are the top competitors of SIDAM?
SIDAM's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
What products or services does SIDAM offer?
SIDAM offers Pressure Measurement Devices, Infusion Systems, and Radiology Devices.
Who are SIDAM's investors?
SIDAM has 2 investors. Key investors include European Union, and Mandarin Capital Partners.